Total planned funding: $339,353,861
Allocations
Countries/Regions
| Eswatini | $339,353,861 |
Organizational Types
| Private Contractor | $90,694,472 |
| University | $62,476,350 |
| NGO | $61,321,481 |
| Unknown | $54,346,433 |
| Own Agency | $39,731,882 |
| Host Country Government Agency | $10,931,898 |
| FBO | $10,806,488 |
| Multi-lateral Agency | $4,335,650 |
| Other USG Agency | $4,092,376 |
| Implementing Agency | $616,831 |
Program Areas
| Treatment | $98,944,056 |
| Care | $89,019,544 |
| Prevention | $65,650,991 |
| Governance and Systems | $36,054,745 |
| Management and Operations | $25,396,882 |
| Testing | $24,287,643 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $79,682,516 |
| HBHC: Care: Adult Care and Support | $35,933,769 |
| HKID: Care: Orphans and Vulnerable Children | $33,107,401 |
| HVMS: Management and Operations | $25,396,882 |
| HVCT: Testing: HIV Testing and Counseling | $24,287,643 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $22,353,166 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $21,388,934 |
| OHSS: Health Systems Strengthening | $15,078,359 |
| HVSI: Strategic Information | $14,899,251 |
| HVTB: Care: TB/HIV | $13,673,528 |
| HTXD: Treatment: ARV Drugs | $12,098,524 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $11,874,423 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $9,549,468 |
| PDTX: Treatment: Pediatric Treatment | $7,163,016 |
| PDCS: Care: Pediatric Care and Support | $6,304,846 |
| HLAB: Laboratory Infrastructure | $6,077,135 |
| HMBL: Biomedical Prevention: Blood Safety | $485,000 |
| HMIN: Biomedical Prevention: Injection Safety | $0 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Columbia University:
$52,252,667
Countries/Regions
Pact, Inc.:
$39,077,378
Countries/Regions
Not Available:
$35,383,580
Countries/Regions
USG Aggregated Agencies:
$17,545,860
Countries/Regions